Report Overview
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.
The global PD-1 and PD-L1 Inhibitors market size was estimated at USD 39550 million in 2023 and is projected to reach USD 207150.84 million by 2032, exhibiting a CAGR of 20.20% during the forecast period.
North America PD-1 and PD-L1 Inhibitors market size was estimated at USD 14183.23 million in 2023, at a CAGR of 17.31% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global PD-1 and PD-L1 Inhibitors market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-1 and PD-L1 Inhibitors Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-1 and PD-L1 Inhibitors market in any manner.
Global PD-1 and PD-L1 Inhibitors Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Bristol-Myers Squibb
Roche
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Merck KGaA
Market Segmentation (by Type)
PD-1 Inhibitors
PD-L1 Inhibitors
Market Segmentation (by Application)
Solid Tumors
Blood-related Tumors
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PD-1 and PD-L1 Inhibitors Market
Overview of the regional outlook of the PD-1 and PD-L1 Inhibitors Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of PD-1 and PD-L1 Inhibitors
1.2 Key Market Segments
1.2.1 PD-1 and PD-L1 Inhibitors Segment by Type
1.2.2 PD-1 and PD-L1 Inhibitors Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-1 and PD-L1 Inhibitors Market Overview
2.1 Global Market Overview
2.1.1 Global PD-1 and PD-L1 Inhibitors Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global PD-1 and PD-L1 Inhibitors Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-1 and PD-L1 Inhibitors Market Competitive Landscape
3.1 Global PD-1 and PD-L1 Inhibitors Sales by Manufacturers (2019-2025)
3.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Manufacturers (2019-2025)
3.3 PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-1 and PD-L1 Inhibitors Average Price by Manufacturers (2019-2025)
3.5 Manufacturers PD-1 and PD-L1 Inhibitors Sales Sites, Area Served, Product Type
3.6 PD-1 and PD-L1 Inhibitors Market Competitive Situation and Trends
3.6.1 PD-1 and PD-L1 Inhibitors Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-1 and PD-L1 Inhibitors Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-1 and PD-L1 Inhibitors Industry Chain Analysis
4.1 PD-1 and PD-L1 Inhibitors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of PD-1 and PD-L1 Inhibitors Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-1 and PD-L1 Inhibitors Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2019-2025)
6.3 Global PD-1 and PD-L1 Inhibitors Market Size Market Share by Type (2019-2025)
6.4 Global PD-1 and PD-L1 Inhibitors Price by Type (2019-2025)
7 PD-1 and PD-L1 Inhibitors Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-1 and PD-L1 Inhibitors Market Sales by Application (2019-2025)
7.3 Global PD-1 and PD-L1 Inhibitors Market Size (M USD) by Application (2019-2025)
7.4 Global PD-1 and PD-L1 Inhibitors Sales Growth Rate by Application (2019-2025)
8 PD-1 and PD-L1 Inhibitors Market Consumption by Region
8.1 Global PD-1 and PD-L1 Inhibitors Sales by Region
8.1.1 Global PD-1 and PD-L1 Inhibitors Sales by Region
8.1.2 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region
8.2 North America
8.2.1 North America PD-1 and PD-L1 Inhibitors Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-1 and PD-L1 Inhibitors Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 PD-1 and PD-L1 Inhibitors Market Production by Region
9.1 Global Production of PD-1 and PD-L1 Inhibitors by Region (2019-2025)
9.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2019-2025)
9.3 Global PD-1 and PD-L1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America PD-1 and PD-L1 Inhibitors Production
9.4.1 North America PD-1 and PD-L1 Inhibitors Production Growth Rate (2019-2025)
9.4.2 North America PD-1 and PD-L1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe PD-1 and PD-L1 Inhibitors Production
9.5.1 Europe PD-1 and PD-L1 Inhibitors Production Growth Rate (2019-2025)
9.5.2 Europe PD-1 and PD-L1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan PD-1 and PD-L1 Inhibitors Production (2019-2025)
9.6.1 Japan PD-1 and PD-L1 Inhibitors Production Growth Rate (2019-2025)
9.6.2 Japan PD-1 and PD-L1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China PD-1 and PD-L1 Inhibitors Production (2019-2025)
9.7.1 China PD-1 and PD-L1 Inhibitors Production Growth Rate (2019-2025)
9.7.2 China PD-1 and PD-L1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Merck
10.1.1 Merck PD-1 and PD-L1 Inhibitors Basic Information
10.1.2 Merck PD-1 and PD-L1 Inhibitors Product Overview
10.1.3 Merck PD-1 and PD-L1 Inhibitors Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck PD-1 and PD-L1 Inhibitors SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Bristol-Myers Squibb
10.2.1 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Basic Information
10.2.2 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Overview
10.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Market Performance
10.2.4 Bristol-Myers Squibb Business Overview
10.2.5 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors SWOT Analysis
10.2.6 Bristol-Myers Squibb Recent Developments
10.3 Roche
10.3.1 Roche PD-1 and PD-L1 Inhibitors Basic Information
10.3.2 Roche PD-1 and PD-L1 Inhibitors Product Overview
10.3.3 Roche PD-1 and PD-L1 Inhibitors Product Market Performance
10.3.4 Roche PD-1 and PD-L1 Inhibitors SWOT Analysis
10.3.5 Roche Business Overview
10.3.6 Roche Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca PD-1 and PD-L1 Inhibitors Basic Information
10.4.2 AstraZeneca PD-1 and PD-L1 Inhibitors Product Overview
10.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Product Market Performance
10.4.4 AstraZeneca Business Overview
10.4.5 AstraZeneca Recent Developments
10.5 Ono Pharmaceutical
10.5.1 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Basic Information
10.5.2 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Overview
10.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Market Performance
10.5.4 Ono Pharmaceutical Business Overview
10.5.5 Ono Pharmaceutical Recent Developments
10.6 Regeneron
10.6.1 Regeneron PD-1 and PD-L1 Inhibitors Basic Information
10.6.2 Regeneron PD-1 and PD-L1 Inhibitors Product Overview
10.6.3 Regeneron PD-1 and PD-L1 Inhibitors Product Market Performance
10.6.4 Regeneron Business Overview
10.6.5 Regeneron Recent Developments
10.7 Innovent
10.7.1 Innovent PD-1 and PD-L1 Inhibitors Basic Information
10.7.2 Innovent PD-1 and PD-L1 Inhibitors Product Overview
10.7.3 Innovent PD-1 and PD-L1 Inhibitors Product Market Performance
10.7.4 Innovent Business Overview
10.7.5 Innovent Recent Developments
10.8 Hengrui Medicine
10.8.1 Hengrui Medicine PD-1 and PD-L1 Inhibitors Basic Information
10.8.2 Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Overview
10.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Market Performance
10.8.4 Hengrui Medicine Business Overview
10.8.5 Hengrui Medicine Recent Developments
10.9 Junshi Biosciences
10.9.1 Junshi Biosciences PD-1 and PD-L1 Inhibitors Basic Information
10.9.2 Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Overview
10.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Market Performance
10.9.4 Junshi Biosciences Business Overview
10.9.5 Junshi Biosciences Recent Developments
10.10 Merck KGaA
10.10.1 Merck KGaA PD-1 and PD-L1 Inhibitors Basic Information
10.10.2 Merck KGaA PD-1 and PD-L1 Inhibitors Product Overview
10.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Product Market Performance
10.10.4 Merck KGaA Business Overview
10.10.5 Merck KGaA Recent Developments
11 PD-1 and PD-L1 Inhibitors Market Forecast by Region
11.1 Global PD-1 and PD-L1 Inhibitors Market Size Forecast
11.2 Global PD-1 and PD-L1 Inhibitors Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe PD-1 and PD-L1 Inhibitors Market Size Forecast by Country
11.2.3 Asia Pacific PD-1 and PD-L1 Inhibitors Market Size Forecast by Region
11.2.4 South America PD-1 and PD-L1 Inhibitors Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of PD-1 and PD-L1 Inhibitors by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global PD-1 and PD-L1 Inhibitors Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of PD-1 and PD-L1 Inhibitors by Type (2025-2032)
12.1.2 Global PD-1 and PD-L1 Inhibitors Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of PD-1 and PD-L1 Inhibitors by Type (2025-2032)
12.2 Global PD-1 and PD-L1 Inhibitors Market Forecast by Application (2025-2032)
12.2.1 Global PD-1 and PD-L1 Inhibitors Sales (K MT) Forecast by Application
12.2.2 Global PD-1 and PD-L1 Inhibitors Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-1 and PD-L1 Inhibitors Market Size Comparison by Region (M USD)
Table 5. Global PD-1 and PD-L1 Inhibitors Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Manufacturers (2019-2025)
Table 7. Global PD-1 and PD-L1 Inhibitors Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2022)
Table 10. Global Market PD-1 and PD-L1 Inhibitors Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers PD-1 and PD-L1 Inhibitors Sales Sites and Area Served
Table 12. Manufacturers PD-1 and PD-L1 Inhibitors Product Type
Table 13. Global PD-1 and PD-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-1 and PD-L1 Inhibitors
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-1 and PD-L1 Inhibitors Market Challenges
Table 22. Global PD-1 and PD-L1 Inhibitors Sales by Type (K MT)
Table 23. Global PD-1 and PD-L1 Inhibitors Market Size by Type (M USD)
Table 24. Global PD-1 and PD-L1 Inhibitors Sales (K MT) by Type (2019-2025)
Table 25. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2019-2025)
Table 26. Global PD-1 and PD-L1 Inhibitors Market Size (M USD) by Type (2019-2025)
Table 27. Global PD-1 and PD-L1 Inhibitors Market Size Share by Type (2019-2025)
Table 28. Global PD-1 and PD-L1 Inhibitors Price (USD/MT) by Type (2019-2025)
Table 29. Global PD-1 and PD-L1 Inhibitors Sales (K MT) by Application
Table 30. Global PD-1 and PD-L1 Inhibitors Market Size by Application
Table 31. Global PD-1 and PD-L1 Inhibitors Sales by Application (2019-2025) & (K MT)
Table 32. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2019-2025)
Table 33. Global PD-1 and PD-L1 Inhibitors Sales by Application (2019-2025) & (M USD)
Table 34. Global PD-1 and PD-L1 Inhibitors Market Share by Application (2019-2025)
Table 35. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate by Application (2019-2025)
Table 36. Global PD-1 and PD-L1 Inhibitors Sales by Region (2019-2025) & (K MT)
Table 37. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2019-2025)
Table 38. North America PD-1 and PD-L1 Inhibitors Sales by Country (2019-2025) & (K MT)
Table 39. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2019-2025) & (K MT)
Table 41. South America PD-1 and PD-L1 Inhibitors Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Region (2019-2025) & (K MT)
Table 43. Global PD-1 and PD-L1 Inhibitors Production (K MT) by Region (2019-2025)
Table 44. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) by Region (2019-2025)
Table 45. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2019-2025)
Table 46. Global PD-1 and PD-L1 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America PD-1 and PD-L1 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe PD-1 and PD-L1 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan PD-1 and PD-L1 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China PD-1 and PD-L1 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Merck PD-1 and PD-L1 Inhibitors Basic Information
Table 52. Merck PD-1 and PD-L1 Inhibitors Product Overview
Table 53. Merck PD-1 and PD-L1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Merck Business Overview
Table 55. Merck PD-1 and PD-L1 Inhibitors SWOT Analysis
Table 56. Merck Recent Developments
Table 57. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Basic Information
Table 58. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Overview
Table 59. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Bristol-Myers Squibb Business Overview
Table 61. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors SWOT Analysis
Table 62. Bristol-Myers Squibb Recent Developments
Table 63. Roche PD-1 and PD-L1 Inhibitors Basic Information
Table 64. Roche PD-1 and PD-L1 Inhibitors Product Overview
Table 65. Roche PD-1 and PD-L1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Roche PD-1 and PD-L1 Inhibitors SWOT Analysis
Table 67. Roche Business Overview
Table 68. Roche Recent Developments
Table 69. AstraZeneca PD-1 and PD-L1 Inhibitors Basic Information
Table 70. AstraZeneca PD-1 and PD-L1 Inhibitors Product Overview
Table 71. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Recent Developments
Table 74. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Basic Information
Table 75. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Overview
Table 76. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Ono Pharmaceutical Business Overview
Table 78. Ono Pharmaceutical Recent Developments
Table 79. Regeneron PD-1 and PD-L1 Inhibitors Basic Information
Table 80. Regeneron PD-1 and PD-L1 Inhibitors Product Overview
Table 81. Regeneron PD-1 and PD-L1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Regeneron Business Overview
Table 83. Regeneron Recent Developments
Table 84. Innovent PD-1 and PD-L1 Inhibitors Basic Information
Table 85. Innovent PD-1 and PD-L1 Inhibitors Product Overview
Table 86. Innovent PD-1 and PD-L1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Innovent Business Overview
Table 88. Innovent Recent Developments
Table 89. Hengrui Medicine PD-1 and PD-L1 Inhibitors Basic Information
Table 90. Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Overview
Table 91. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Hengrui Medicine Business Overview
Table 93. Hengrui Medicine Recent Developments
Table 94. Junshi Biosciences PD-1 and PD-L1 Inhibitors Basic Information
Table 95. Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Overview
Table 96. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Junshi Biosciences Business Overview
Table 98. Junshi Biosciences Recent Developments
Table 99. Merck KGaA PD-1 and PD-L1 Inhibitors Basic Information
Table 100. Merck KGaA PD-1 and PD-L1 Inhibitors Product Overview
Table 101. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Merck KGaA Business Overview
Table 103. Merck KGaA Recent Developments
Table 104. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2025-2032) & (K MT)
Table 105. Global PD-1 and PD-L1 Inhibitors Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2025-2032) & (K MT)
Table 107. North America PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2025-2032) & (K MT)
Table 109. Europe PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2025-2032) & (K MT)
Table 111. Asia Pacific PD-1 and PD-L1 Inhibitors Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2025-2032) & (K MT)
Table 113. South America PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa PD-1 and PD-L1 Inhibitors Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Type (2025-2032) & (K MT)
Table 117. Global PD-1 and PD-L1 Inhibitors Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global PD-1 and PD-L1 Inhibitors Price Forecast by Type (2025-2032) & (USD/MT)
Table 119. Global PD-1 and PD-L1 Inhibitors Sales (K MT) Forecast by Application (2025-2032)
Table 120. Global PD-1 and PD-L1 Inhibitors Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of PD-1 and PD-L1 Inhibitors
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-1 and PD-L1 Inhibitors Market Size (M USD), 2019-2032
Figure 5. Global PD-1 and PD-L1 Inhibitors Market Size (M USD) (2019-2032)
Figure 6. Global PD-1 and PD-L1 Inhibitors Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-1 and PD-L1 Inhibitors Market Size by Country (M USD)
Figure 11. PD-1 and PD-L1 Inhibitors Sales Share by Manufacturers in 2023
Figure 12. Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers in 2023
Figure 13. PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-1 and PD-L1 Inhibitors Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-1 and PD-L1 Inhibitors Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-1 and PD-L1 Inhibitors Market Share by Type
Figure 18. Sales Market Share of PD-1 and PD-L1 Inhibitors by Type (2019-2025)
Figure 19. Sales Market Share of PD-1 and PD-L1 Inhibitors by Type in 2023
Figure 20. Market Size Share of PD-1 and PD-L1 Inhibitors by Type (2019-2025)
Figure 21. Market Size Market Share of PD-1 and PD-L1 Inhibitors by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-1 and PD-L1 Inhibitors Market Share by Application
Figure 24. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2019-2025)
Figure 25. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2023
Figure 26. Global PD-1 and PD-L1 Inhibitors Market Share by Application (2019-2025)
Figure 27. Global PD-1 and PD-L1 Inhibitors Market Share by Application in 2023
Figure 28. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate by Application (2019-2025)
Figure 29. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2019-2025)
Figure 30. North America PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2023
Figure 32. U.S. PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada PD-1 and PD-L1 Inhibitors Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico PD-1 and PD-L1 Inhibitors Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2023
Figure 37. Germany PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific PD-1 and PD-L1 Inhibitors Sales and Growth Rate (K MT)
Figure 43. Asia Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2023
Figure 44. China PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America PD-1 and PD-L1 Inhibitors Sales and Growth Rate (K MT)
Figure 50. South America PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2023
Figure 51. Brazil PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa PD-1 and PD-L1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global PD-1 and PD-L1 Inhibitors Production Market Share by Region (2019-2025)
Figure 62. North America PD-1 and PD-L1 Inhibitors Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe PD-1 and PD-L1 Inhibitors Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan PD-1 and PD-L1 Inhibitors Production (K MT) Growth Rate (2019-2025)
Figure 65. China PD-1 and PD-L1 Inhibitors Production (K MT) Growth Rate (2019-2025)
Figure 66. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global PD-1 and PD-L1 Inhibitors Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global PD-1 and PD-L1 Inhibitors Market Share Forecast by Type (2025-2032)
Figure 70. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Application (2025-2032)
Figure 71. Global PD-1 and PD-L1 Inhibitors Market Share Forecast by Application (2025-2032)
